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Abstract
Osteoarthritis (OA) is the most common form of arthritis worldwide with no effective treatment. Ageing is the primary
risk factor for OA. We sought to investigate if there is a distinct and functional convergence of ageing-related
mechanisms SIRT1 and autophagy in chondrocytes. Our results show that, levels of SIRT1 are decreased in human
normal aged and OA cartilage compared with young cartilage. Moreover, silencing SIRT1 in chondrocytes lead to
decreased expression of chondrogenic markers but did not alter the expression of catabolic proteases. In contrast,
activation of SIRT1 increased autophagy in chondrocytes by the deacetylation of lysine residues on crucial autophagy
proteins (Beclin1, ATG5, ATG7, LC3). This activation was shown to be mTOR/ULK1 independent. Our results indicate
that maintenance of autophagy in chondrocytes by SIRT1 is essential for preserving cartilage integrity throughout life
and therefore is a target for drug intervention to protect against OA.
Introduction
Osteoarthritis (OA) is the most common form of
arthritis1. There are no effective therapeutic options for
OA and joint replacement still remains the most common
approach to treat the disease. The primary risk factor for
OA is increased age, where over time cartilage tissue
degrades. SIRT1, a class III histone deacetylase, controls
lifespan extension and age-related cellular mechanisms
including stress responses, circadian rhythm and genetic
repair2. Decreased expression of SIRT1 is linked with age-
associated disease (e.g., neurodegeneration, ischaemic
heart disease, diabetes)3 while pharmacological stimula-
tion increases lifespan and prevents age-related dis-
orders4. Observational studies have also linked SIRT1 to
abnormal chondrocyte biology and OA5–7. Similarly, the
process of autophagy (self-eating), where unwanted pro-
teins are degraded and recycled, decreases with age and
OA and is linked to the pathobiology of ageing-related
disorders8–10.
Recent evidence draws associations between both
ageing-related processes, where SIRT1 significantly
increased autophagy in aged chondrocytes, while reduced
expression of SIRT1 lowered autophagy in young chon-
drocytes11. SIRT1 activation of autophagy may be linked
to microRNAs or the AMPK/mTOR pathways in chon-
drocytes12,13. However, the direct regulation of autophagy
in cartilage by SIRT1 are still unclear11–13. The aim of this
study was to investigate if SIRT1 directly binds and dea-
cetylates autophagy proteins in chondrocytes and if SIRT1
positively influences chondrogenic markers. The dysre-
gulation of such chondrogenic markers are common in
ageing cartilage cells and OA tissues.
Here, we show SIRT1 levels decrease in human OA
which in turn decreased chondrogenic markers alongside
key autophagy markers. Activation of SIRT1 increased
chondrocyte autography alongside chondrogenesis which
suggests a beneficial role of the SIRT1-autophagy axis in
chondrocytes. Most importantly, we show SIRT1 to bind
and directly deacetylase several autophagy proteins
(ULK1, BECLIN1, ATG5, ATG7 and LC3 I/II). These
results suggest a direct action of SIRT1 upon autophagy-
linked proteins in chondrocytes, the targeting of which
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may be beneficial for enhanced chondrogenesis and the
prevention of OA.
Results
Loss of SIRT1 expression disrupts cartilage homoeostatic
markers
Normal human cartilage samples from aged individuals
showed decreased SIRT1 protein levels compared with
young and were further decreased in OA samples (Fig. 1a, b).
SIRT1 siRNA knockdown in healthy isolated human
articular chondrocytes (HACs) (Fig. 1c–g) and HTB-94
cells (Supplementary Fig. S1a–e), reduced chondrogenic
markers, SOX9, type 2 collagen (COL2A1) and aggrecan
(ACAN). In support of these findings, pharmacological
inhibition (EX-527) of SIRT1 reduced the expression of
COL2A1, ACAN and SOX-9 (Fig. 1h–l). Conversely, the
expression of the key chondrogenic markers increased
when SIRT1 activity was stimulated by SRT1720 (Fig. 1h–l).
Fig. 1 Loss of SIRT1 expression disrupts cartilage homoeostatic markers. a SIRT1 protein expression (b) and quantification in isolated
chondrocytes from young healthy (21–37 years), old (62–68 years) and OA (49–86 years) knee joints. c Protein expression of cartilage markers in
isolated chondrocytes from young healthy (21–37 years) transfected with SIRT1 siRNA or control siRNA (n= 3). d–g RT-qPCR analysis of cartilage
marker expressions in isolated chondrocytes from young healthy (21–37 years) following SIRT1 siRNA or control siRNA transfection (n= 3). h Protein
expression of cartilage marker expressions in HTB-94 cells with DMSO control or EX-527 (100 nM) or SRT1720 (500 nM) (n= 3). i–l RT-qPCR analysis of
cartilage marker expressions in HTB-94 cells treated with DMSO control or EX-527 (100 nM) or SRT1720 (500 nM) (n= 3). All RT-qPCR gene expressions
were normalised to the endogenous level of 18 s. All data are expressed as mean ± S.E.M of n observations. Students unpaired t-test or ANOVA with
Tukeys comparison were used for statistical analysis. NS= non-significant. p < 0.05, p < 0.01, p < 0.001 or p < 0.0001 represented in all figures as *, **,
*** or **** respectively.
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Silencing of SIRT1 does not affect major catabolic enzymes
in chondrocytes
The maintenance of cartilage integrity and OA-disease
progression are both associated with an adequate bal-
ance of chondrocyte formation and function, and local
levels of matrix-degrading proteases. Silencing SIRT1
did not affect the expression of the critical extracellular
matrix (ECM) degrading proteases MMP-13 and
ADAMTS-5 in HACs (Fig. 2a, b). However, loss of
SIRT1 augmented the increase in MMP-13 and
ADAMTS-5 gene and protein expression induced by
catabolic stimuli (IL-1β or TNFα) above that seen in
control cells (Supplementary Fig. S2c–j).
Chondrocyte autophagy is SIRT1 dependent
We next examined the role of autophagy in aged and
diseased cartilage, and its putative link with SIRT1.
Interestingly, the gene and protein expression of critical
autophagy-related genes ULK1, BECLIN1 and LC3, were
regulated in line with molecular (Fig. 3a–e and
Fig. 2 Silencing of SIRT1 does not affect major catabolic enzymes in chondrocytes. a, bmRNA expression of catabolic proteases in HTB-94 cells
following SIRT1 siRNA or control siRNA transfection (n= 3). c protein expression and (d–f) mRNA of SIRT1, MMP13 and ADAMTS-5 in isolated
chondrocytes from young healthy (21–37 years) treated with SIRT1 siRNA or control siRNA+/− IL1-β (n= 3). g protein expression (h–j) and mRNA of
SIRT1, MMP13 and ADAMTS-5 in isolated chondrocytes from young healthy (21–37 years) treated with SIRT1 siRNA or control siRNA+/− TNF-α (n= 3).
All RT-qPCR gene expressions were normalised to the endogenous level of 18 s. All data are expressed as mean ± S.E.M of n observations. Students
unpaired t-test or ANOVA with Tukeys comparison were used for statistical analysis. NS= non-significant. p < 0.01 or p < 0.0001 represented in all
figures as ** or **** respectively.
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supplementary Fig. S2a-e) and pharmacological alteration
of SIRT1 (Fig. 3f–j). In support of this data, SIRT1-
induced changes in autophagy were quantified in treated
chondrocytes using flow cytometry and by assessing LC3-
GFP intensity. The conversion from LC3-I to LC3-II is
indicative of increased autophagy14. LC3 II mean fluor-
escent intensity (MFI) increased by 213.5% when SIRT1
was activated, whereas inhibiting SIRT1 decreased
significantly LC3 II MFI by 42.17% (Fig. 3k, l). This
finding was supported by studies using LC3-GFP reporter
mice, where isolated primary chondrocytes treated as
above, showed decreased LC3-GFP+ puncta (54.37%)
and staining intensity per cell (66.8%) following SIRT1
inhibition, and a 20.5% increase in LC3-GFP+ puncta and
staining per cell (28.0%) upon stimulation (Fig. 3m, n and
supplementary Fig. S3f, g).
Fig. 3 Chondrocyte autophagy is dependent on SIRT1. a Protein levels and (b–e) RT-qPCR analysis of autophagy marker expression in isolated
chondrocytes from young healthy (21–37 years) transfected with SIRT1 siRNA or control siRNA (n= 3). f Protein expression of cartilage marker
expressions in HTB-94 cells with DMSO control or EX-527 (100 nM) or SRT1720 (500 nM) (n= 3). g–j RT-qPCR analysis of cartilage marker expressions
in HTB-94 cells treated with DMSO control or EX-527 (100 nM) or SRT1720 (500 nM) (n= 3). k Histogram and (l) quantification of mean fluorescence
intensity (MFI) of LC3-II in HTB-94 cells either untreated or treated with bafilomycin A1 (BAF; 10 nM), alongside DMSO (vehicle control), for 2 h (n= 3).
m Quantification of total LC3-GFP intensity per chondrocyte and (n) percentage of chondrocytes with LC3 positive punctate from cartilaginous
femoral heads of LC3-GFP mice. Femoral heads were treated with either DMSO control or EX-527 (100 nM) or SRT1720 (500 nM) for 2 h before fixation
(n= 30–50 cells from 3 mice per group). All RT-qPCR gene expressions were normalised to the endogenous level of 18 s. All data are expressed as
mean ± S.E.M of n observations. Students unpaired t-test or ANOVA with Tukeys comparison were used for statistical analysis. NS= non-significant.
p < 0.05, p < 0.01, p < 0.001 or p < 0.0001 represented in all figures as *, **, *** or **** respectively.
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SIRT1 directly interacts and activates autophagy proteins
in chondrocytes
To ascertain whether changes in SIRT1 and autophagy
were linked or occurring independently, immunoprecipi-
tation analysis was performed to determine which
autophagy-related proteins directly interact with SIRT1.
Several autophagy mediators including BECLIN1, ATG5,
ATG7 and LC3, but excluding ULK1, were shown to bind
the SIRT1 protein (Fig. 4a). Moreover, each protein was
functionally modified through its interaction with SIRT1
Fig. 4 SIRT1 directly interacts and activates autophagy proteins in chondrocytes. a Western blot showing the binding of autophagy markers
using immunoprecipitation assays against SIRT1 in HTB-94 cells (n= 3). b–e Western blots showing representative acetylation status (total acetyl
lysine) and total protein expression of immunoprecipitated (IP) Atg5, Atg7, BECLIN1 and LC3 in HTB-94 cells treated with DMSO (control), EX-527
(100 nM) or SRT1720 (500 nM). β-Actin from input (IN) lysate is shown as loading control (n= 3). f–j Ratio of acetyl lysine compared to total protein of
autophagy markers in HTB-94 cells treated with DMSO (control), EX-527 (100 nM) or SRT1720 (500 nM) (n= 3). k SIRT1 and autophagy are decreased
in aged and OA tissue. Activating SIRT1 in chondrocytes increases autophagy by direct deacetylation. All data are expressed as mean ± S.E.M of
n observations. ANOVA with Tukeys comparison was used. p < 0.05 or p < 0.01 represented in figures as * or ** respectively.
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demonstrated by increased acetylation of common
representative sites when SIRT1 was pharmacologically
blocked (EX-527), and by decreased acetylation in the
presence of a SIRT1 activator (SRT1720) (Fig. 4b–k and
supplementary Fig. S3a).
Discussion
We have shown that both SIRT1 and autophagy are
similarly dysregulated in human chondrocytes from age-
ing and OA cartilage that a direct functional relationship
exists between both longevity-linked factors. Collectively,
this data suggests that the decreasing levels of SIRT1 in
human chondrocytes with increasing age, and further loss
of expression in OA samples may underlie the patho-
genesis of OA and decreased cartilage integrity during
ageing. The convergence of two accepted ageing-related
mechanisms in the pathogenesis of osteoarthritis there-
fore seems highly likely.
The sirtuin family of deacetylase enzymes are known to
be dependent on the local availability of Nicotinamide
adenine dinucleotide (NAD+) for efficient activity to
occur. Consequently, metabolic alterations resulting in
leading to changes in the NADH/NAD+ ratio, have
potential to indirectly impact the range of cellular pro-
cesses controlled by Sirtuin proteins, such as mitochon-
drial biogenesis and insulin sensitivity, and which includes
SirT1 activity. Interestingly, the loss of SIRT1 and the
NAD+ co-factor, are shown to be decreased in OA
patients and experimental models of bone and joint dis-
ease5–7,15–17. Recent observational studies in mice suggest
that loss of SIRT1 in all chondrocytes through use of the
type II collagen promoter, predisposed to OA develop-
ment at 1 year18. Interestingly, our studies show impaired
COL2A119, SOX-920 and ACAN21 expression but no early
change in MMP-13 or ADAMTS5 expression following
SIRT1 deletion in HACs. As shown by other studies
MMP-13 and ADAMTS-5 only changed following a
catabolic stimuli (IL-1β or TNFα) alongside SIRT1
loss5,22. This suggests the regulation of NFκB activation by
SIRT1 is an important mechanism in response to cata-
bolic stimuli in cells including chondrocytes23,24. Our
results also suggest increased protease activity occurs
following a reduction in SIRT1 levels which has in turn,
compromised the intrinsic capacity of chondrocytes to
function adequately by impairing autophagy. The post-
translational modification of autophagy proteins has
recently been reported to exert significant control over
autophagic activity25. Specifically, elevated acetylation of
BECLIN1 reduced autophagosome maturation in cancer
cells26, increased deacetylation of LC3 promoted autop-
hagy following caloric restriction27 and SIRT1 deacetyla-
tion of LC3 has been shown to effectively redistribute LC3
in an activated form from nucleus to cytoplasm control-
ling total LC3 levels28,29. This is in accordance with our
findings where increased acetylation of key autophagy
proteins was brought about by loss of SIRT1. Decreased
mTOR/ULK1 signalling also increases autophagy to pro-
tect against OA30,31. Here we demonstrate a new role for
SIRT1 in targeting downstream autophagic proteins, but
interestingly, through the binding and activation of ULK1,
which alludes to a separate regulation of autophagy
independent of the mTOR/ULK1 signalling pathway.
We also observed SIRT1-mediated changes in mRNA of
autophagy markers suggesting SIRT1 might exert tran-
scriptional control of autophagy alongside post-
translational modifications. This might be explained by
the direct deacetylation of the autophagy-related Tran-
scription factor EB (TFEB) by SIRT132. SIRT1 deacetyla-
tion promotes TFEB activity to increase autophagy33.
Similarly, SIRT1 has multiple targets34 in many cell types
including chondrocytes, such as Set7/9, Sox-9,
TNFα19,20,35–37 which might also influence how SIRT1
pathways connect to or control chondrocyte autophagy in
this system and ageing overall.
These data indicate that the convergence of two well-
accepted ageing-related mechanisms may underlie the
development of OA. Whilst further rescue studies tar-
geting SIRT1 and autophagy-related proteins in OA tis-
sues will provide valuable information indicating a
causative role in OA pathogenesis, this work has identified
new direct interactions between SIRT1 and autophagy-
related proteins where functional modifications and
changes in autophagic flux are dependent upon SIRT1
expression in chondrocytes. Moreover, the data suggests
that declining expression of SIRT1 with increasing age
predisposes to OA by impairing autophagy. Targeting the
SIRT1-autophagy axis pharmacologically may therefore
preserve cartilage integrity, and represent a viable, cost-
effective and well tolerated approach to the
management of OA.
Materials and methods
Isolation of human chondrocytes
Healthy or OA knee/hip cartilage was obtained from
surgical patients (21–86 years old). Tissue samples were
collected with informed donor consent in full compliance
with national and institutional ethical requirements, the
United Kingdom Human Tissue Act, and the Declaration
of Helsinki. Dissected cartilage pieces were incubated
overnight in Dulbecco’s modified Eagle’s medium
(DMEM) with 1mg/ml Collagenase A (Roche Pharma-
ceuticals) at 37 °C for 5–6 h to isolate cells. Cells used in
experiments were at passage 1.
Cell culture
HTB-94 chondrosarcoma cells were obtained from the
American Type Culture Collection cultured in DMEM
containing 4.5 g/l of glucose and L-glutamine (Lonza),
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10% foetal calf serum (PAA Laboratories), 1% Penicillin
and Streptomycin (Cambrex), Amphotericin B (Gibco)
and HEPES solution (Cambrex). Cells were negative for
mycoplasma contamination.
SIRT1 siRNA transfection
Healthy isolated human chondrocytes or HTB-94 cells
were wet reverse transfected with Dharmacon ON-
TARGETplus SMARTpool (4 oligos) human
SIRT1 siRNA (25 nM) (Dharmacon Technologies). A
scramble oligo sequence was used as control (25 nM)
(Dharmacon Technologies).
Drug and cytokine treatments
Cells were seeded at 300,000 cells per well in 6 well
plates in complete DMEM media and cultured containing
EX-527 (inhibitor of SIRT1; 100 nM; Sigma-Aldrich),
SRT1720 (activator of SIRT1; 500 nM; Selleckchem) or
the control of DMSO (Sigma-Aldrich). Forty-eight hours
after SIRT1 siRNA transfection, healthy human chon-
drocytes were treated with 10 ng/ml of IL-1β (PeproTech)
or TNF-α (PeproTech) for 24 h.
FACS
Autophagy was measured by quantifying LC3-II mean
fluorescence intensity using the FlowCellect Autophagy
LC3 Antibody-based Assay Kit (Merk-Millipore) accord-
ing to the manufacturer’s instructions after HTB-94 cells
were treated with drugs as described above.
Protein analysis
Cells were homogenised in lysis buffer (RIPA buffer;
Sigma-Aldrich), Ethylenediaminetetraacetic acid free
protease inhibitor (Roche Pharmaceuticals), Phosphatase
inhibitor cocktail 2 and 3 (Sigma-Aldrich) and protein
levels quantified by bicinchoninic acid assay (Thermo
Fisher Scientific). For western blot analysis samples were
probed overnight with primary antibody: Human SIRT1
(#9475; 1:1000; Cell Signalling Technology, MA, U.S.A),
Mouse SIRT1 (07–131; 1:1000; Millipore, Massachusetts,
U.S.A) or Beta-actin (β-actin) (A2228; 1:20000; Sigma-
Aldrich), COL2A1 (SAB4500366; 1:1000; Sigma-Aldrich),
SOX-9 (ab26414; 1:1000; Abcam, Cambridge, U.K.),
ULK1 (NBP2-24738; 1:1000; Novus Biologicals, Cam-
bridge, UK), Beclin1 (NB500-249; 1:1000; Novus Biolo-
gicals), LC3 (NB100-2220; 1:1000; Novus Biologicals),
ATG5 (#12994; 1:1000; Cell Signalling Technology);
ATG7 (#8558; 1:1000; Cell Signalling Technology),
Acetyl-Lysine Antibody (#9441; 1:1000; Cell Signalling
Technology), P62/SQSTM1 (NBP1-48320; 1:1000; Novus
Biologicals). Secondary horseradish peroxidase (HRP)-
conjugated anti-rabbit (#7074; 1:5000; Cell Signalling
Technology), Secondary HRP-conjugated anti-mouse
(#7076; 1:5000; Cell Signalling Technology)
RNA isolation and quantitative PCR
Total RNA was isolated from cell cultures using RNeasy
Mini Kit (Qiagen) as per manufacturer’s instructions. RT-
qPCR was carried out on a ViiA™ 7 Real-Time PCR
System (Applied Biosystems) with TaqMan probes (Sup-
plementary Table 1). Relative gene expression was ana-
lysed by the ΔΔCt method using 18 s as an endogenous
control gene.
LC3-GFP studies
Femoral heads from LC3-GFP mice (donated by Pro-
fessor K. Simon, University of Oxford) were avulsed and
placed in DMEM media containing either EX-527
(100 nM) or SRT1720 (500 nM) or DMSO. For positive
controls, serum free DMEM containing either EX-527
(100 nM) or SRT1720 (500 nM) or DMSO was used. After
an incubation of 2 h, femoral heads were embedded in
Optimal Cutting Temperature liquid (CellPath) and snap-
frozen. Thereafter, samples were cryosectioned at 10 µm.
Fluorescence images were taken using an excitation
wavelength of 473 nm and a band-path of 490−540 nm.
Bright field images were obtained using scattering wave-
length of 635 nm. The cells were segmented in bright field
and GFP intensity was measured in fluorescent channel.
Intensity of background was subtracted from intensities of
individual cells and divided by intensity of background in
order to normalise and score cells. The number of LC3
puncta per cell was counted throughout each z stacks by
two blinded operators.
Immunoprecipitation
SIRT1 or autophagy-related proteins were immunopre-
cipitated after 24 h treatment of HTB-94 cells treated with
DMSO (control), EX-527 (100 nM) or SRT1720 (500 nM)
using a CO-IP commercially available kit (Pierce). Total
acetyl lysine or autophagy targets for the respective
experiments were detected by western blotting. β-Actin
from input whole lysate was used as loading control.
Statistical analysis
All data are expressed as mean ± standard error of mean
(S.E.M) of n observations. Experiments were statistically
analysed utilising the Students unpaired t-test for para-
metric data with independent groups compared with their
specific controls or time-matched controls. One-way
analysis of variance (ANOVA) with Tukeys comparison
test was used to compare 3 or more groups. A significant
difference was accepted when p < 0.05, p < 0.01, p < 0.001
or p < 0.0001 represented in all tables and figures as *, **,
*** or **** respectively. Data analysis was performed using
GraphPad Prism® 5.0 (GraphPad Software, California,
U.S.A). We calculated sample size according to estab-
lished power calculations on previous work in the lab,
published literature and availability of sample population.
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